Physostigmine hemisulfate is a derivative of Physostigmine (sc-202764). Physostigmine hemisulfate is an alkaloid originally derived from the Calabar bean Physostigma venenosum. Physostigmine hemisulfate is noted to act as a potent and reversible inhibitor of cholinesterase. Physostigmine hemisulfate is also reported to form a slowly degrading carbamylated enzyme complex with acetylcholinesterase (AChE). Physostigmine hemisulfate has been used as a positive control in a study investigating acetylcholinesterase inhibitors for potential antihelminthic drug targets. Additionally, this parasympathomimetic compound is reported to cross the blood-brain barrier in a research study.
1. Tamaddonfard, E. and Hamzeh-Gooshchi, N. 2010. Pharmacol Rep. 62: 858-863. PMID: 21098868
2. Valli, M., et al. 2011. Curr Med Chem. [Epub ahead of print]. PMID: 21728957
3. Kalogiannis, M., et al. 2011. PLoS ONE. 6: e18697. PMID: 21533254
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.